Abstract
Thirtytwo male beagle dogs were used in 16 cross-circulation experiments wherein arterial blood from one dog (donor) was perfused at constant flow rate through a hind limb (HL) of another dog (recipient). The HL innervation remained intact. Exposure of the donor to 67–70% CBrF 3 was accompanied by a reversible decrease in the donor's mean arterial blood pressure. The HL perfusion pressure (and therefore vascular resistance in HL) was unaltered. Exposure of the recipient to 67–70% CBrF 3 was accompanied by a reversible decrease in the recipient mean arterial blood pressure and HL perfusion pressure. The HL perfusion pressure change was greatly attenuated by pretreatment of the HL with phenoxybenzamine and abolished by pretreatment of the recipient with hexamethonium. Nictitating membrane tension and vagal inhibition of the heart in response to electrical stimulation of the corresponding cut ends of the vagosympathetic trunks were measured in 5 dogs before, during and after exposure to 80% CBrF 3. The CBrF 3 exposure was accompanied by a reversible decrease in both nictitating membrane tension and vagal inhibition of the heart. The mechanism of the decrease in mean arterial blood pressure during CBrF 3 exposure was concluded to be a decrease in vasomotor tone resulting from ganglionic blockade. No direct vascular smooth muscle effect of CBrF 3 was observed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.